中草药

桑黄中性多糖结构特征及其通过调控肠道菌群改善小鼠肝纤维化的作用机制

PDF下载

中草药 | 药理与临床 2026,57(12): 4644-4661

收起

中草药 |药理与临床 2026 , 57 (12) : 4644 -4661

桑黄中性多糖结构特征及其通过调控肠道菌群改善小鼠肝纤维化的作用机制

全屏

许秋莹¹, 姚路蒙¹, 王星星¹, 高珍洁¹, 高思琦¹, 吴建军¹, 秦路平¹

作者信息

通讯作者:

吴建军

作者简介:

许秋莹: 许秋莹，女，硕士研究生，研究方向为中药物质基础研究。E-mail:ying1002233@163.com

Structural characteristics of neutral polysaccharides from Sanghuangporus vaninii and their mechanism of ameliorating liver fibrosis in mice by regulating gut microbiota

XU Qiuying, YAO Lumeng, WANG Xingxing, GAO Zhenjie, GAO Siqi, WU Jianjun, QIN Luping

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.12.012

文章导航

摘要

收起

目的表征桑黄水部位多糖（water-eluted fraction of Sanghuangporus vaninii polysaccharides，SHP-W）的结构特征，并探讨其调节肠道菌群改善四氯化碳（carbon tetrachloride，CCl₄）诱导的小鼠肝纤维化的作用机制。方法采用水提醇沉、弱阴离子交换色谱法从桑黄Sanghuangporus vaninii子实体中制备得到SHP-W。采用苯酚硫酸法、间羟基联苯法和BCA法测定SHP-W的总糖、糖醛酸和蛋白含量，通过高效尺寸排阻色谱法（high performance size exclusion chromatography，HPSEC）、傅里叶红外光谱法（fourier transform infrared spectrophotometer，FT-IR）、离子色谱法（ion chromatography，IC）和甲基化结合气相色谱-质谱联用（gas chromatography and mass spectrometry，GC-MS）等对SHP-W的结构特征进行表征。C57BL/6J小鼠ip 15% CCl₄-橄榄油溶液6周构建肝纤维化模型，给予SHP-W（25、50、100 mg/kg）或索拉非尼（10 mg/kg）干预3周，采用苏木素-伊红（hematoxylin-eosin，HE）、天狼星红和Masson染色观察小鼠肝脏的病理形态学改变；采用全自动生化分析仪分析血清丙氨酸氨基转移酶（alanine aminotransferase，ALT）、天冬氨酸氨基转移酶（aspartate aminotransferase，AST）、总胆汁酸（total bile acids，TBA）、总胆红素（total bilirubin，TBIL）和直接胆红素（direct bilirubin，DBIL）水平；采用免疫组化法检测肝组织I型胶原（collagen-I，Col-I）和α-平滑肌肌动蛋白（α-smooth muscle actin，α-SMA）的表达；采用Western blotting检测肝组织Col-I、α-SMA和转化生长因子-β1（transforming growth factor-β1，TGF-β1）的蛋白表达；采用16S rDNA测序分析肠道菌群，并采用抗生素干扰验证菌群作用。结果 SHP-W是由2个不同相对分子质量（1.818×10⁴、2.040×10³）的多糖组成的部位多糖，其总糖质量分数为（88.27±3.76）%，不含糖醛酸和蛋白质。单糖组成结果显示SHP-W由半乳糖、甘露糖和岩藻糖以及葡萄糖组成，物质的量比为34.6∶23.0∶22.7∶19.7，同时含有3-O-甲基半乳糖；甲基化分析显示SHP-W由1,3,6-Glcp等14种糖苷键组成。动物实验结果显示，与对照组比较，模型组小鼠血清AST、ALT、TBIL、DBIL和TBA水平显著升高（P＜0.001），肝细胞索排列紊乱，炎性细胞浸润明显，出现大量的纤维组织增生，肝组织中Col-I、α-SMA和TGF-β1蛋白表达显著上调（P＜0.05、0.001）；与模型组比较，各给药组小鼠肝组织的假小叶及汇管区胶原纤维沉积均有不同程度改善，血清肝功能水平显著降低（P＜0.05、0.01、0.001），肝组织Col-I、α-SMA和TGF-β1蛋白表达下调（P＜0.05、0.01、0.001）。抗生素干扰后，SHP-W改善肝纤维化的效果被显著抑制。结论从桑黄子实体中制备得到SHP-W，糖醛酸含量测定、红外光谱以及单糖组成显示其为中性多糖。SHP-W可显著改善血清肝功能、抑制HSCs活化、减少胶原纤维沉积从而改善CCl₄诱导的小鼠肝纤维化，且其抗肝纤维化作用依赖于对肠道微生物的调节。

关键词

桑黄中性多糖 / 结构特征 / 单糖组成 / 肝纤维化 / 肠道菌群 / 肝星状细胞活化 / 胶原纤维沉积

Abstract

收起

Objective To analyze the structural characteristics of water-eluted fraction of Sanghuangporus vaninii polysaccharides (SHP-W) and explore the mechanism of SHP-W on improving carbon tetrachloride (CCl₄)-induced liver fibrosis in mice by regulating gut microbiota. Methods SHP-W was extracted from S. vaninii using water extraction and ethanol precipitation, followed by purification through weak anion-exchange chromatography. The total sugar, uronic acid and protein contents of SHP-W were determined by phenol sulfuric acid method, m-hydroxybiphenyl method and BCA method. The structural characterization of SHP-W was carried out by high performance size exclusion chromatography (HPSEC), Fourier transform infrared spectrophotometer (FT-IR), ion chromatography (IC) and methylation combined gas chromatography-mass spectrometry (GC-MS). C57BL/6J mice were prepared with a 15% CCl₄ olive oil solution via ip for six weeks to establish a liver fibrosis model. SHP-W (25, 50, 100 mg/kg) or sorafenib (10 mg/kg) were administered for three weeks, and the pathological morphological changes in liver tissues were observed using hematoxylin-eosin (HE), sirius red and Masson staining. A fully automated biochemical analyzer was used to analyze the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bile acids (TBA), total bilirubin (TBIL) and direct bilirubin (DBIL) in serum. Immunohistochemistry was used to detect the expressions of collagen-I (Col-I) and α-smooth muscle actin (α-SMA) in liver tissue. Western blotting was used to detect the expressions of Col-I, α-SMA and transforming growth factor-β1 (TGF-β1) proteins in liver tissue. 16S rDNA sequencing was used to analyze the gut microbiota, and antibiotic interference was used to verify the role of the microbiota. Results SHP-W was a refined polysaccharide composed of two polysaccharides with different relative molecular weights (1.818 × 10⁴, 2.040 × 10³), with a total sugar content of (88.27 ± 3.76)%, and without uronic acid and protein. The monosaccharide composition results showed that SHP-W was composed of galactose, mannose, fucose and glucose, with a molar ratio of 34.6∶23.0∶22.7∶19.7, and also contained 3-O-methylgalactose. Methylation analysis showed that SHP-W was composed of 14 glycosidic bonds, including 1,3,6-Glcp.The animal experiment results showed that compared with control group, the levels of AST, ALT, TBIL, DBIL and TBA in serum of mice in model group were significantly increased (P < 0.001), the arrangement of liver cell cords was disordered, inflammatory cell infiltration was obvious, and a large amount of fibrous tissue proliferation was appeared, the expressions of Col-I, α-SMA and TGF-β1 protein in liver tissue was significantly up-regulated (P < 0.05, 0.001). Compared with model group, the collagen fiber deposition in pseudo lobules and portal area of liver tissue of mice in each treatment group was improved to varying degrees, and the serum liver function level was significantly reduced (P < 0.05, 0.01, 0.001), the expressions of Col-I, α-SMA and TGF-β1 protein in liver tissue was down-regulated (P < 0.05, 0.01, 0.001). After antibiotic interference, the effect of SHP-W on improving liver fibrosis was significantly inhibited. Conclusion SHP-W were prepared from S. vaninii fruiting bodies, the determination of uronic acid content, infrared spectroscopy and monosaccharide composition showed that SHP-W were neutral polysaccharide. SHP-W could significantly improve serum liver function, inhibit HSCs activation, reduce collagen fiber deposition, and thus improve CCl₄-induced liver fibrosis in mice. Its anti-fibrotic effect depends on the regulation of gut microbiota.

Key words

neutral polysaccharides from Sanghuangporus vaninii (Ljub) L. W. Zhou et Y. C. Dai / structural characteristics / monosaccharide composition / liver fibrosis / gut microbiota / activation of hepatic stellate cells / collagen fiber deposition

引用本文

许秋莹, 姚路蒙, 王星星, 高珍洁, 高思琦, 吴建军, 秦路平. 桑黄中性多糖结构特征及其通过调控肠道菌群改善小鼠肝纤维化的作用机制. 中草药, 2026 , 57 (12) : 4644 -4661 . DOI: 10.7501/j.issn.0253-2670.2026.12.012

XU Qiuying, YAO Lumeng, WANG Xingxing, GAO Zhenjie, GAO Siqi, WU Jianjun, QIN Luping. Structural characteristics of neutral polysaccharides from Sanghuangporus vaninii and their mechanism of ameliorating liver fibrosis in mice by regulating gut microbiota[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (12) : 4644 -4661 . DOI: 10.7501/j.issn.0253-2670.2026.12.012

基金

收起

浙江省自然科学基金项目 (ZCLY24H2801); 浙江中医药大学“5151远志人才工程” (112123A12201/001/004/019); 浙江中医药大学科研项目 (2023RCZXZK20)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Moreira R K. Hepatic stellate cells and liver fibrosis [J]. Arch Pathol Lab Med, 2007, 131(11): 1728-1734.
Kim J W, Tung H C, Ke M Y, et al. The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis [J]. Hepatology, 2025, 82(1): 92-109.
Liu S H, Wan H, Yang L, et al. High prevalence of steatotic liver disease and fibrosis in the general population: A large prospective study in China [J]. J Hepatol, 2025, 82(1): e23-e25.
Lu J L, Yu C X, Song L J. Programmed cell death in hepatic fibrosis: Current and perspectives [J]. Cell Death Discov, 2023, 9(1): 449.
Hu X Q, Song Y N, Wu R, et al. Metabolic mechanisms of Fuzheng-Huayu Formula against liver fibrosis in rats [J]. J Ethnopharmacol, 2019, 238: 111888.
邓莉, 申宝德, 刘园, 等. 复方鳖甲软肝片减方对CCl₄诱导大鼠肝纤维化的影响及机制研究[J]. 中草药, 2018, 49(6): 1371-1378.
Chen X F, Sun X, Ji S X, et al. TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan Decoction in improving hepatic fibrosis [J]. J Ethnopharmacol, 2024, 319(Pt 3): 117334.
霍子璇, 李佳楠, 窦元枫, 等. 桃红四物汤抑制肝细胞双硫死亡改善肝纤维化的作用机制[J]. 中草药, 2025, 56(18): 6632-6643.
岳杉杉, 彭安康, 马泽江, 等. 柚皮素通过调控TGF-β1/ Smad通路抑制肝纤维化[J]. 中国药理学通报, 2022, 38(2): 248-254.
周林华, 陈晓. 栀子苷通过TGF-β1/Smad信号通路抑制肝纤维化和肝星状细胞活化[J]. 生理学报, 2022, 74(2): 217-224.
Mu M, Zuo S, Wu R M, et al. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [J]. Drug Des Devel Ther, 2018, 12: 4107-4115.
戴鸿志, 安祯祥, 黄丹, 等. 黄芪甲苷对肝纤维化模型大鼠的改善作用机制研究[J]. 中国现代应用药学, 2022, 39(10): 1268-1274.
郑洋, 卢能源, 黄永贤, 等. 基于TGF-β1/Smad信号通路探讨莪术醇对肝纤维化小鼠作用的实验研究[J]. 中华中医药学刊, 2021, 39(11): 149-152.
张鹏, 郑世豪, 苟思媛, 等. 中药复方逆转肝纤维化及早期肝硬化的作用机制[J]. 临床肝胆病杂志, 2024, 40(9): 1873-1879.
杨鹏, 杨增艳. 中药单体在抗肝纤维化中的研究进展[J]. 大医生, 2025, 10(2): 132-135.
Liang C, Liu J J, Jiang M X, et al. The advancement of targeted regulation of hepatic stellate cells using traditional Chinese medicine for the treatment of liver fibrosis [J]. J Ethnopharmacol, 2025, 341: 119298.
Liu W, Zhang L Z, Wei X, et al. Structural characterization of an inulin neoseries-type fructan from Ophiopogonis Radix and the therapeutic effect on liver fibrosis in vivo [J]. Carbohydr Polym, 2024, 327: 121659.
Dai X L, Du Z Y, Jin C, et al. Inulin-like polysaccharide ABWW may impede CCl₄ induced hepatic stellate cell activation through mediating the FAK/PI3K/Akt signaling pathway in vitro & in vivo [J]. Carbohydr Polym, 2024, 326: 121637.
Chen C, Liu X, Qi S S, et al. Hepatoprotective effect of Phellinus linteus mycelia polysaccharide (PL-N1) against acetaminophen-induced liver injury in mouse [J]. Int J Biol Macromol, 2020, 154: 1276-1284.
Zhao L L, Zheng L W, Li Z, et al. Phellinus linteus polysaccharides mediates acetaminophen-induced hepatotoxicity via activating AMPK/Nrf2 signaling pathways [J]. Aging, 2022, 14(17): 6993-7002.
Song Q Q, Wang Y K, Huang L X, et al. Review of the relationships among polysaccharides, gut microbiota, and human health [J]. Food Res Int, 2021, 140: 109858.
Zhang P C, Li J, Miao Y F, et al. Sheng-Jiang powder ameliorates NAFLD via regulating intestinal microbiota in mice [J]. Front Microbiol, 2024, 15: 1387401.
Jiang Z L, He L Q, Li D Y, et al. Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control [J]. Nat Metab, 2025, 7(4): 808-822.
Yang Y, Zhang J S, Liu Y F, et al. Structural elucidation of a 3-O-methyl-D-galactose-containing neutral polysaccharide from the fruiting bodies of Phellinus igniarius [J]. Carbohydr Res, 2007, 342(8): 1063-1070.
Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression [J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166.
Zhang X T, Zeng Y, Zhao L Y, et al. Targeting hepatic stellate cell death to reverse hepatic fibrosis [J]. Curr Drug Targets, 2023, 24(7): 568-583.
Delzenne N M, Bindels L B, Neyrinck A M, et al. The gut microbiome and dietary fibres: Implications in obesity, cardiometabolic diseases and cancer [J]. Nat Rev Microbiol, 2025, 23: 225-238.
Hong Y H, Li H, Chen L K, et al. Short-term exposure to antibiotics begets long-term disturbance in gut microbial metabolism and molecular ecological networks [J]. Microbiome, 2024, 12(1): 80.
Wu X, Chen C W, Zhang H Y, et al. Exploration of chemical components and Rac1-dependent anti-hepatic fibrosis mechanism by total flavonoids derived from Tetrastigma hemsleyanum [J]. Chin Herb Med, 2025, 17(4): 837-849.
Huang S C, Wang P W, Kuo P C, et al. Hepatoprotective principles and other chemical constituents from the mycelium of Phellinus linteus [J]. Molecules, 2018, 23(7): 1705.
Qin D D, Han S, Liu M L, et al. Polysaccharides from Phellinus linteus: A systematic review of their extractions, purifications, structures and functions [J]. Int J Biol Macromol, 2023, 230: 123163.
Dong Y, Qiu P, Zhao L S, et al. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis [J]. Phytomedicine, 2020, 74: 152697.
张珈宁, 瞿海燕, 张金梦, 等. 桑黄多糖缓解日本血吸虫感染小鼠氧化应激及肝纤维化的实验研究[J]. 中国血吸虫病防治杂志, 2019, 31(6): 615-621.
Qu Y H, Zhang P P, Cui J, et al. Extraction optimization, structure analysis and antioxidant activity of polysaccharide from Sanghuangporus baumii [J]. Curr Anal Chem, 2024, 20(4): 264-274.
刘利娜. 桑黄多糖分离纯化、结构表征及其活性研究[D]. 合肥: 安徽中医药大学, 2023.
Sun Y Q, Huo J X, Zhong S, et al. Chemical structure and anti-inflammatory activity of a branched polysaccharide isolated from Phellinus baumii [J]. Carbohydr Polym, 2021, 268: 118214.
Yan J K, Wang Y Y, Ma H L, et al. Structural characteristics and antioxidant activity in vivo of a polysaccharide isolated from Phellinus linteus mycelia [J]. J Taiwan Inst Chem Eng, 2016, 65: 110-117.
Keung W S, Zhang W H, Luo H Y, et al. Correlation between the structures of natural polysaccharides and their properties in regulating gut microbiota: Current understanding and beyond [J]. Carbohydr Polym, 2025, 352: 123209.
Lei P, Li X G, Jiang L, et al. Alisma plantago-Aquatica polysaccharides ameliorate acetaminophen-induced acute liver injury by regulating hepatic metabolic profiles and modulating gut microbiota [J]. Int J Biol Macromol, 2025, 285: 138345.
Liao J B, Cao Y J, Zhao J, et al. Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver [J]. Phytomedicine, 2023, 118: 154937.

2026年第57卷第12期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.12.012

接收时间：2025-10-25
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-10-25

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.12.012

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT